Delivery Order SPE2DB20D7061-SPE2DB24FSMW2
Award Date
3/28/24
Potential Completion Date
3/29/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a ceiling value of $14,307.57 and a period of performance through May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a ceiling value of $17,370.01 and a performance period through May 19, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any particular business type. Amerisourcebergen Drug Corp...
This is a $16,913.70 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the procurement of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a performance period through June 4, 2024. This delivery order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 1 GM/50 MLS, a type of prescription medication. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $2,286.48. The ultimate completion date for this delivery order is May 20, 2025. Amerisourcebergen Drug Corp is the prime...
This is a Delivery Order contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. The contract has a Firm Fixed Price pricing type and a ceiling value of $6,121.99. The ultimate completion date is May 10, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of Cefepime-Dextrose 2 gram/50 milliliter pharmaceutical products, with a ceiling value of $3,443.69 and a performance period through April 5, 2024. This award is a firm fixed price delivery order under a larger indefinite delivery contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The order is for 4,563,917,745 units of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. The total ceiling value of the order is $7,411.34, and it is a firm fixed price contract. The order has a performance period through March 12, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is the prime contractor...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. The contract has a firm fixed price of $9,801.72 and a period of performance through April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,821.52, is for the provision of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product. The contract has an ultimate completion date of May 17, 2023 and is a Firm Fixed Price type contract. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is for the delivery of Cefepime-Dextrose 2 GM/50 ML medical supplies, with a ceiling value of $1,971.48 and a completion date of September 21, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...